Period of time： 2013年4期
Publisher： Future Science
Founded in： 2012
Total resources： 5
ISSN： 2046-8954
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Pharmaceutical Patent Analyst,volume 2,issue 4
Menu
Patentability of biologics in Canada: beyond patentable subject matter
By Aumand Livia,Norman John in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 4 , Vol. 2, Iss. 4, 2013-07 , pp.
Access to resources
Recommend
By Grossman Jonathan E,Hanish John P in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 4 , Vol. 2, Iss. 4, 2013-07 , pp.Association of University Technology Managers Asia 2013 conference
By Komatani Takeshi S in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 4 , Vol. 2, Iss. 4, 2013-07 , pp.By Sklan Alexandra,Komatani Takeshi S in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 4 , Vol. 2, Iss. 4, 2013-07 , pp.Post-Therasense inequitable conduct: a pharmaceutical perspective
By Carson Patricia A,Forchheimer Daniel,Draper David N in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 4 , Vol. 2, Iss. 4, 2013-07 , pp.Small-molecule inhibitors of I&kgr;B kinase (IKK) and IKK-related kinases
By Llona-Minguez Sabin,Baiget Jessica,Mackay Simon P in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 4 , Vol. 2, Iss. 4, 2013-07 , pp.Nanocoatings on implantable medical devices
By Arsiwala Ammar M,Raval Ankur J,Patravale Vandana B in (2013)
Pharmaceutical Patent Analyst,volume 2,issue 4 , Vol. 2, Iss. 4, 2013-07 , pp.
Previous
Next